• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽在正常和帕金森病患者大脑中的区域分布。

Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects.

作者信息

Jégou S, Javoy-Agid F, Delbende C, Tranchand-Bunel D, Coy D H, Agid Y, Vaudry H

机构信息

UA CNRS 650, Unité Alliée à l'INSERM Université de Rouen, Mont-Saint-Aignan, France.

出版信息

Peptides. 1988 Jul-Aug;9(4):787-93. doi: 10.1016/0196-9781(88)90123-4.

DOI:10.1016/0196-9781(88)90123-4
PMID:3226955
Abstract

The distribution of vasoactive intestinal peptide (VIP) in the post-mortem human brain was determined by radioimmunoassay using a highly specific antiserum. The detection limit of the assay was 4 fmol/tube. The highest concentrations of VIP were found in the cerebral cortex, amygdala, hypothalamus and hippocampus. The lowest levels of peptide were detected in basal ganglia including caudate nucleus, external pallidum, putamen and substantia nigra. All dilution curves of acetic acid extracts from different brain areas were strictly parallel to the standard curve. Sephadex G-50 gel filtration of frontal cortex extract showed that VIP-like immunoreactivity (VIP-LI) eluted as a major peak comigrating with synthetic hVIP. Detailed mapping of VIP in the human cerebral cortex showed the existence of a rostro-caudal gradient of VIP-LI concentrations: the frontal cortex exhibited the highest VIP levels, the parietal and temporal cortex contained medium values and the occipital cortex contained the lowest VIP levels. The concentrations of VIP-LI were compared in various regions of the human brain from normal and parkinsonian subjects. No significant changes in VIP-LI levels occurred in the brains of patients dying with Parkinson's disease. No difference in VIP levels could be found either when the parkinsonian group was subdivided into nondemented and demented patients. These data indicate that VIP-containing neurons are not affected in parkinsonian patients. Our results also suggest that VIP neuronal systems are not involved in the course of dementing process in Parkinson's disease.

摘要

使用高特异性抗血清,通过放射免疫分析法测定了尸检人脑内血管活性肠肽(VIP)的分布。该分析方法的检测限为4 fmol/管。在大脑皮质、杏仁核、下丘脑和海马中发现VIP浓度最高。在包括尾状核、外苍白球、壳核和黑质在内的基底神经节中检测到的肽水平最低。来自不同脑区的乙酸提取物的所有稀释曲线都与标准曲线严格平行。额叶皮质提取物的Sephadex G - 50凝胶过滤显示,VIP样免疫反应性(VIP - LI)作为与合成人VIP共迁移的主要峰洗脱。在人类大脑皮质中对VIP进行详细定位显示,存在VIP - LI浓度的前后梯度:额叶皮质VIP水平最高,顶叶和颞叶皮质含量中等,枕叶皮质VIP水平最低。比较了正常人和帕金森病患者人脑不同区域的VIP - LI浓度。死于帕金森病的患者大脑中VIP - LI水平没有显著变化。当将帕金森病组细分为非痴呆和痴呆患者时,也未发现VIP水平有差异。这些数据表明,帕金森病患者中含VIP的神经元未受影响。我们的结果还表明,VIP神经元系统不参与帕金森病的痴呆过程。

相似文献

1
Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects.血管活性肠肽在正常和帕金森病患者大脑中的区域分布。
Peptides. 1988 Jul-Aug;9(4):787-93. doi: 10.1016/0196-9781(88)90123-4.
2
In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.关于猫大脑皮层和脑室周围结构中胆囊收缩素和血管活性肠肽基础释放及诱发释放的体内研究。
Brain Res. 1983 Nov 28;280(1):105-17. doi: 10.1016/0006-8993(83)91178-2.
3
Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.小鼠大脑皮层和视交叉上核中血管活性肠肽(VIP)、肽组氨酸异亮氨酸(PHI)和肽组氨酸缬氨酸(PHV)的浓度及分布
Brain Res. 1994 Sep 5;656(1):95-107. doi: 10.1016/0006-8993(94)91370-6.
4
Substance P immunoreactivity in the post-mortem parkinsonian brain.帕金森病患者死后大脑中的P物质免疫反应性。
Brain Res. 1984 Jun 11;303(1):113-6. doi: 10.1016/0006-8993(84)90217-8.
5
Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat.
Peptides. 1989 May-Jun;10(3):621-6. doi: 10.1016/0196-9781(89)90153-8.
6
Radioimmunologic localization of vasoactive intestinal polypeptide in hypothalamic and extrahypothalamic sites in the rat brain.大鼠脑中血管活性肠肽在下丘脑及下丘脑外部位的放射免疫定位
Neurosci Lett. 1979 May;12(2-3):265-9. doi: 10.1016/0304-3940(79)96073-7.
7
Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.中枢神经系统中肽组氨酸 - 异亮氨酸/血管活性肠多肽免疫反应性神经元的分析,特别提及它们与下丘脑室旁核中促肾上腺皮质激素释放因子和脑啡肽样免疫反应性的关系。
Neuroscience. 1987 Dec;23(3):827-57. doi: 10.1016/0306-4522(87)90162-x.
8
VIP in the rat brain: evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis.大鼠脑中的血管活性肠肽:通过终纹床核连接杏仁核和下丘脑的主要通路的证据。
Histochemistry. 1980 Feb;65(2):103-19. doi: 10.1007/BF00493159.
9
The distribution of cholecystokinin and vasoactive intestinal peptide in rhesus monkey brain as determined by radioimmunoassay.
Neuropeptides. 1983 Jul;3(5):337-44. doi: 10.1016/0143-4179(83)90022-7.
10
Regional distribution of vasoactive intestinal peptide immunoreactivity in the brain of salmon, trout and carp.鲑鱼、鳟鱼和鲤鱼大脑中血管活性肠肽免疫反应性的区域分布。
Biol Signals. 1995 Mar-Apr;4(2):86-93. doi: 10.1159/000109426.

引用本文的文献

1
Vasoactive intestinal polypeptide plasma levels associated with affective symptoms and brain structure and function in healthy females.与健康女性的情感症状和大脑结构与功能相关的血管活性肠肽血浆水平。
Sci Rep. 2021 Jan 14;11(1):1406. doi: 10.1038/s41598-020-80873-2.
2
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases.垂体腺苷酸环化酶激活多肽和血管活性肠肽对神经退行性疾病认知功能衰退的保护作用
Front Cell Neurosci. 2020 Jul 17;14:221. doi: 10.3389/fncel.2020.00221. eCollection 2020.
3
Vasoactive intestinal polypeptide immunoreactivity in the human cerebellum: qualitative and quantitative analyses.
人类小脑血管活性肠肽免疫反应:定性和定量分析。
J Anat. 2009 Sep;215(3):256-66. doi: 10.1111/j.1469-7580.2009.01110.x. Epub 2009 Jun 22.
4
Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.衰老与疾病中神经肽的改变。病理生理学及临床干预潜力。
Drugs Aging. 1993 Sep-Oct;3(5):408-27. doi: 10.2165/00002512-199303050-00003.